Northwest Biotherapeutics reported 10.4M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Applied Genetic Technologies AGTC:US $ 16.42M 2.14M
AstraZeneca AZN:LN 11.54B 4.45B
Bristol Myers Squibb BMY:US $ 9.63B 360M
Celldex Therapeutics CLDX:US $ 20.98M 4.06M
Cti Biopharma CTIC:US $ 23.38M 3.88M
Cytori Therapeutics CYTX:US $ 3.5M 924K
Cytrx CYTR:US 1.53M 351.4K
Eisai 4523:JP Y 157959M 14472M
Genocea Biosciences GNCA:US $ 13.36M 1.19M
Infinity Pharmaceuticals INFI:US $ 11.18M 585K
Merk MRK:US $ 8328M 1460M
Mirati Therapeutics MRTX:US $ 151.29M 12.89M
Northwest Biotherapeutics NWBO:US 10.4M 2.56M
Pfizer PFE:US $ 16447M 3384M
Sunesis Pharmaceuticals SNSS:US $ 14.8M 5.74M